CA
NZ
UK
AU
IND
US
The outlook matters more because a stock price corresponds to expected future earnings, whereas the headline EPS number describes a quarter that has already ended. A beat shows what happened. Guidance shows what the leadership team anticipates next, so investors compare it with consensus …
Merck KGaA agreed on Monday, October 19 to acquire Silence Therapeutics (Nasdaq: SLN) for $20 per American depositary share in cash, valuing the company at roughly $1.3 billion. The price is 130% above the previous close and 82% above the 30-day volume-weighted average of …
Mortgage rates generally move with the 10-year Treasury yield, which makes homebuilders sensitive to bond markets. On October 22 the 10-year yield was 4.96%, down 17 basis points, a calculated figure, from 5.13% the day in advance of, as stated in Treasury data. It …
Illinois Tool Works (NYSE:ITW) will report third-quarter 2026 results on Tuesday, October 27, not on Friday, October 23. The release is due at 7:00 a.m. Central time, and subsequently a webcast at 9:00 a.m. The central consideration is whether the acceleration seen during the …
On Friday, October 23, Infosys (NYSE:INFY) announces results for the second quarter of fiscal 2027, the reporting period ended September 30,, as stated in a company notice issued on October 19. Its American depositary receipts finished at $13.22 on Thursday, October 22, up 3.69%, …
Why Do Investors Sell Good News? How Capex, Guidance, Options Pricing and Capital Returns Shape Reactions
The near-term schedule is thin. Two Nasdaq IPOs are slated this week: Davion Healthcare (Nasdaq: DAVI) on October 22 with 25 million shares, and Lycia Therapeutics (Nasdaq: LYCA) on October 23 with 14.7 million shares at $16 to $18, an anticipated $250 million. No …
Six companies with cancer programs, tests or planned acquisitions moved on Friday, October 23, 2026, and the group spans very different stages of development. Estrella Immunopharma (NASDAQ:ESLA) rose 11.24% to $0.8085 with its EB103 lymphoma therapy in dose expansion, and Tvardi Therapeutics (NASDAQ:TVRD) gained …
Seven sub-$5 stocks dropped between roughly 10% and 16% on Friday, October 23, 2026, and the companies have not announced a separate catalyst. Top Wealth Group (NASDAQ:TWG) fell 15.68% to $0.0398 one session before a 1-for-100 consolidation, and Quhuo (NASDAQ:QH) fell 14.93% to $3.02 …
Eight sub-$5 stocks gained between roughly 8% and 11% on Friday, October 23, 2026, and none of the companies has announced a catalyst. Estrella Immunopharma (NASDAQ:ESLA) rose 11.24% to $0.8085 with cash of $0.1 million, and Tvardi Therapeutics (NASDAQ:TVRD) rose 10.08% to $1.0702 ahead …
Please wait processing your request...